Mb Michael Miller (ASCP)

Michael Miller, MB(ASCP), has a strong background in laboratory work with experience spanning over 14 years. Michael currently serves as a Senior Laboratory Technologist at GRAIL, a position they have held since April 2022.

Prior to joining GRAIL, Michael worked at the North Carolina State Laboratory of Public Health for over 7 years. During their time there, they served as a Molecular Laboratory Specialist, where they acted as the lead technologist, primary trainer, and subject matter expert for various laboratory procedures, including qRT-PCR, Sanger sequencing, and Next-Generation Sequencing. Michael also performed verification and training for targeted sequencing of SARS-CoV-2 using Illumina MiSeq instruments. Additionally, Michael served as a Medical Laboratory Technologist, where they conducted chemical testing and ensured the validity and quality of patient samples.

Before their tenure at the North Carolina State Laboratory of Public Health, Michael worked at Quest Diagnostics as a Medical Technologist II. In this role, they performed viral, bacterial, and genetic procedures, verified and released results using LIS, and ensured compliance with regulations.

Michael's earlier experience includes working as a Molecular Technologist I at UMass Medical School, where they maintained high-quality standards in a fast-paced environment and used LIS to release results to physicians. Michael also made contributions to the development of variations in MassARRAY technology for Cystic Fibrosis diagnosis.

Additionally, Michael gained experience as a Laboratory Assistant at Hooke Laboratories in 2008.

Overall, Michael Miller, MB(ASCP), has developed a diverse skill set in molecular laboratory techniques and has made significant contributions in their roles throughout their career.

Michael Miller, MB(ASCP), pursued their education in the field of microbiology. Michael attended the University of New Hampshire from 2005 to 2009, where they obtained their Bachelor of Science (B.S.) degree in Microbiology. In January 2014, they also obtained a certification as a Technologist in Molecular Biology from the American Society for Clinical Pathology.